Quoin Pharmaceuticals, Ltd. CEO Michael Myers' 2023 pay falls 36% to $1.3M

Quoin Pharmaceuticals, Ltd. reports 2023 executive compensation

By ExecPay News

Published: 2 hours ago

Quoin Pharmaceuticals, Ltd. reported fiscal year 2023 executive compensation information on October 24, 2024.
In 2023, three executives at Quoin Pharmaceuticals, Ltd. received on average a compensation package of $1M, a 41% decrease compared to previous year.
Average pay of disclosed executives at Quoin Pharmaceuticals, Ltd.
Michael Myers, Chief Executive Officer, received $1.3M in total, which decreased by 36% compared to 2022. 48% of Myers' compensation, or $602K, was in salary. Myers also received $301K in bonus, $292K in option awards, as well as $60K in other compensation.
Denise Carter, Chief Operating Officer, received a compensation package of $1.1M, which decreased by 41% compared to previous year. 45% of the compensation package, or $482K, was in salary.
Gordon Dunn, Chief Financial Officer, earned $776K in 2023, a 46% decrease compared to previous year.

Related executives

Michael Myers

Quoin Pharmaceuticals, Ltd.

Chief Executive Officer

Denise Carter

Quoin Pharmaceuticals, Ltd.

Chief Operating Officer

Gordon Dunn

Quoin Pharmaceuticals, Ltd.

Chief Financial Officer

You may also like

Source: SEC filing on October 24, 2024.